Vosaroxin for acute myeloid leukemia
The treatment of acute myeloid leukemia (AML) in adults has not significantly changed in the past five decades. Despite the availability of effective induction chemotherapy, most patients eventually relapse. Relapsed or refractory AML, and AML in patients 60 years of age and older are particularly d...
Saved in:
| Main Author: | El-Amm, Joelle (author) |
|---|---|
| Other Authors: | Tabbara, Imad A. (author) |
| Format: | article |
| Published: |
2014
|
| Online Access: | http://hdl.handle.net/10725/6262 http://dx.doi.org/10.4155/CLI.13.126 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://www.openaccessjournals.com/articles/vosaroxin-for-acute-myeloid-leukemia.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Doxironide magnetic nanoparticles for selective drug delivery to human acute myeloid leukemia
by: Abi-Habib, Ralph
Published: (2017) -
A multicenter experience from Lebanon in childhood and adolescent acute myeloid leukemia
by: Farhat, Hussein Z.
Published: (2015) -
Therapeutic Impact of P-PENT, P-HEX and 5CLSS (IV) Platinum (IV) complexes on Acute Myeloid Leukemia in vitro and in vivo
by: Bou Chacra, Joelle
Published: (2025) -
Acute Myeloid Leukemia in Qatar (2010–2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes
by: Halima El Omri (14778790)
Published: (2020) -
The anticancer effect of β-2 himachalen-6-ol from Lebanese wild carrot on human acute myeloid leukemia cells. (c2016)
by: Boulos, Joelle C.
Published: (2016)